XPEV XPeng Inc tops Q4 2025 EPS estimates by wide margin shares climb nearly 5 percent on upbeat investor reaction Johnson Johnson JNJ Icotyde Partnership Drives Portfolio Expansion and DeRisked Biotech Upside BWNB Babcock 2026 Q4 2025 earnings outperform forecasts as EPS turns positive against projected quarterly loss